| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/2009 | WO2009016577A3 A pharmaceutical composition comprising atorvastatin and niacin |
| 03/26/2009 | WO2009016564A3 2-aza-bicyclo[3.3.0]octane derivatives |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | WO2009016462A3 Substituted bicyclolactam compounds |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | WO2009015368A3 Multikinase inhibitors for use in the treatment of cancer |
| 03/26/2009 | WO2009015274A3 Polyethylene based bioactive agents |
| 03/26/2009 | WO2009015214A3 Nanoparticles for imaging and treating chlamydial infection |
| 03/26/2009 | WO2009015014A3 Multi-step method of pain and/or inflammation treatment |
| 03/26/2009 | WO2009013433A3 Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals |
| 03/26/2009 | WO2009011901A3 Methods for promoting wakefulness |
| 03/26/2009 | WO2009011795A3 Methods for treating stress induced emotional disorders |
| 03/26/2009 | WO2009009793A3 Inhibitors of akt/pkb with anti-tumor activity |
| 03/26/2009 | WO2009009768A3 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 03/26/2009 | WO2009009040A3 Fatty acid compositions and methods of use |
| 03/26/2009 | WO2009007753A3 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 03/26/2009 | WO2009007457A3 Compounds and methods for modulating rho gtpases |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2009004188A3 Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 03/26/2009 | WO2008157614A9 Sustained intraocular delivery of drugs from biodegradable polymeric microparticles |
| 03/26/2009 | WO2008153884A8 Compositions useful for treating gastroesophageal reflux disease |
| 03/26/2009 | WO2008151235A3 Compositions for delivering medicaments into the lungs, uses thereof |
| 03/26/2009 | WO2008151119A3 Compositions and methods for use of scar tissue in repair of weight bearing surfaces |
| 03/26/2009 | WO2008145838A3 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas |
| 03/26/2009 | WO2008145688A3 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | WO2008140571A3 Methods and compositions for treating influenza |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008137780A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
| 03/26/2009 | WO2008135791A8 Imidazoquinolines with immuno-modulating properties |
| 03/26/2009 | WO2008132155A3 Inhibitors of the binding between hdm2 and the proteasome |
| 03/26/2009 | WO2008126943A3 Method for manufacturing neuraminic acid derivatives |
| 03/26/2009 | WO2008118879A3 Antiviral compositions comprising 2 compounds |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | WO2008109490A4 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof |
| 03/26/2009 | WO2008109378A4 Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof |
| 03/26/2009 | WO2008106058A3 Inhibitors of serine proteases |
| 03/26/2009 | WO2008104852A3 Pharmaceutical compositions comprising adsorbate of fenofibrate |
| 03/26/2009 | WO2008094617A3 Crystalline forms of deferasirox |
| 03/26/2009 | WO2008076243A3 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 03/26/2009 | WO2008073318A3 Use of atp in controlled regional reperfusion as treatment during acute myocardial infarction |
| 03/26/2009 | WO2008073193A3 Ocular devices and methods of making and using thereof |
| 03/26/2009 | WO2008058897A3 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 03/26/2009 | WO2008058269A3 Compounds and methods for modulating protein trafficking |
| 03/26/2009 | WO2008053374A3 Topically applied probucol-containing agent with protective and regenerative effect |
| 03/26/2009 | WO2008042422A3 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 03/26/2009 | WO2008039525A3 Cadherin antagonists in combination with anticancer agents for use in cancer treatment |
| 03/26/2009 | WO2008032204A8 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/26/2009 | WO2008017914A3 Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (miscrosponged benzoyl peroxide) |
| 03/26/2009 | WO2008015680A3 Polycyclic dianthraquinones as inhibitors of inflammatory cytokines |
| 03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 03/26/2009 | WO2008005194A4 Method for the eradication of pathogens comprising generating molecular iodine in situ |
| 03/26/2009 | WO2007112287A3 Hme transdermal compositions containing testosterone |
| 03/26/2009 | WO2007092620A3 Stable formulations, and methods of their preparation and use |
| 03/26/2009 | WO2006009568A3 Peripherally-acting vasodilators |
| 03/26/2009 | WO2006004722A3 Compositions and methods for selectively activating human sirtuins |
| 03/26/2009 | WO2006002073A3 Method for preventing heme-induced lipid peroxidation |
| 03/26/2009 | WO2005084295A3 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3 |
| 03/26/2009 | WO2005044977A3 Compositions, splice variants and methods relating to lung specific genes and proteins |
| 03/26/2009 | WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| 03/26/2009 | WO2005018486A3 Use of melatonin-containing oral supplement with animals |
| 03/26/2009 | WO2005011604A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease |
| 03/26/2009 | WO2003070158A3 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 03/26/2009 | US20090082855 Coating for controlled release of a therapeutic agent |
| 03/26/2009 | US20090082738 Natural Anti-Inflammatory Agents for Reducing Pain |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082473 Composition comprising resveratol and its topical use thereof for reducing human hair growth |
| 03/26/2009 | US20090082471 Deuterium-enriched fingolimod |
| 03/26/2009 | US20090082470 Stat3 inhibiting compositions and methods |
| 03/26/2009 | US20090082469 Deuterium-enriched terbinafine |
| 03/26/2009 | US20090082468 Deuterium-enriched levalbuterol |
| 03/26/2009 | US20090082467 Treatment of migraine headaches using antiestrogens |
| 03/26/2009 | US20090082466 Solid oral dosage forms of opioid agonist painkiller, one or more of polyethylene glycol mono- or distearates, water insoluble waxes, glycerol monostearate or hydrogenated vegetable oil; tamper resistant dosage form; prevent or minimizing excessive peak concentrations when taken with alcohol |
| 03/26/2009 | US20090082465 Deuterium-enriched lisdexamfetamine |
| 03/26/2009 | US20090082464 Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/26/2009 | US20090082463 N-substituted phenylacetamide derivative and pharmaceutical composition containing the same |
| 03/26/2009 | US20090082462 Deuterium-enriched armodafinil |
| 03/26/2009 | US20090082461 Deuterium-enriched modafinil |
| 03/26/2009 | US20090082459 Deuterium-enriched guanfacine |
| 03/26/2009 | US20090082458 Deuterium-enriched aliskiren |
| 03/26/2009 | US20090082457 (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide; MEK kinase (mitogen-activated ERK-activating kinases, MAP kinase kinase); cancer, tumors, autoimmune disorders, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis |
| 03/26/2009 | US20090082456 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082455 Therapeutic agent for ophthalmic disease |
| 03/26/2009 | US20090082454 Deuterium-enriched disufenton |
| 03/26/2009 | US20090082452 Deuterium-enriched lumiracoxib |
| 03/26/2009 | US20090082451 Use of thyroid hormone conversion inhibitors |
| 03/26/2009 | US20090082450 Deuterium-enriched diclofenac |
| 03/26/2009 | US20090082449 Spray-Drying Process for Producing a Dry Caritine Powder or Granulate |
| 03/26/2009 | US20090082448 Method for placental exfoliation using oxo-arachidonic acid or the like |
| 03/26/2009 | US20090082447 Pharmaceutical Compositions Containing Omega 3 Fatty Acids |
| 03/26/2009 | US20090082446 Use of Hydroxyoleic acid and related compounds in the manufacture of drugs |
| 03/26/2009 | US20090082445 Gossypol co-crystals and the use thereof |
| 03/26/2009 | US20090082444 Compositions for the Treatment of Blood Disorders |
| 03/26/2009 | US20090082442 Deuterium-enriched lubiprostone |
| 03/26/2009 | US20090082441 Deuterium-enriched tesaglitazar |
| 03/26/2009 | US20090082440 Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/26/2009 | US20090082438 Coordination Compound Composed of Diaminocyclohexane Platinum (II) and Block Copolymer and Anti-Cancer Agent Comprising the Same |
| 03/26/2009 | US20090082437 Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer |
| 03/26/2009 | US20090082436 Deuterium-enriched rivastigmine |